Genedrive PLC shares soared 18% higher after the molecular diagnostics company said it secured UKCA marking for its new Genedrive CYP2C19 System, allowing.
Genedrive PLC on Wednesday said that its CYP2C19 point of care test achieved marking registration in the UK, known as UKCA.
Genedrive shares rose 17% to 13.20 pence each on Wednesday morning in.
Genedrive PLC shares soared 18% higher after the molecular diagnostics company said it secured UKCA marking for its new Genedrive CYP2C19 System, allowing.
Point-of-care molecular diagnostics developer Genedrive announced on Wednesday that its Genedrive CYP2C19 System has received UKCA marking registration.